Harpole D - Search Results

1

Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.

Salgia R, Harpole D, Herndon JE 2nd, Pisick E, Elias A, Skarin AT. Salgia R, et al. Among authors: harpole d. Anticancer Res. 2001 Mar-Apr;21(2B):1241-6. Anticancer Res. 2001. PMID: 11396194

2

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.

Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT, Sugarbaker DJ. Strauss GM, et al. Among authors: harpole dh. J Clin Oncol. 1995 May;13(5):1265-79. doi: 10.1200/JCO.1995.13.5.1265. J Clin Oncol. 1995. PMID: 7738631 Review.

3

Prognostic issues in non-small cell lung cancer.

Harpole DH Jr. Harpole DH Jr. Chest. 1995 Jun;107(6 Suppl):267S-269S. doi: 10.1378/chest.107.6_supplement.267s. Chest. 1995. PMID: 7781404 No abstract available.

4

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

Harpole DH Jr, Herndon JE 2nd, Wolfe WG, Iglehart JD, Marks JR. Harpole DH Jr, et al. Cancer Res. 1995 Jan 1;55(1):51-6. Cancer Res. 1995. PMID: 7805040

5

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.

Harpole DH Jr, Herndon JE 2nd, Young WG Jr, Wolfe WG, Sabiston DC Jr. Harpole DH Jr, et al. Cancer. 1995 Sep 1;76(5):787-96. doi: 10.1002/1097-0142(19950901)76:5<787::aid-cncr2820760512>3.0.co;2-q. Cancer. 1995. PMID: 8625181

6

Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.

Harpole DH Jr, Richards WG, Herndon JE 2nd, Sugarbaker DJ. Harpole DH Jr, et al. Ann Thorac Surg. 1996 May;61(5):1470-6. doi: 10.1016/0003-4975(96)00104-X. Ann Thorac Surg. 1996. PMID: 8633961

7

Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system.

Harpole DH Jr, Healey EA, DeCamp MM Jr, Mentzer SJ, Strauss GM, Sugarbaker DJ. Harpole DH Jr, et al. Ann Surg Oncol. 1996 May;3(3):261-9. doi: 10.1007/BF02306281. Ann Surg Oncol. 1996. PMID: 8726181

8

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

Kwiatkowski DJ, Harpole DH Jr, Godleski J, Herndon JE 2nd, Shieh DB, Richards W, Blanco R, Xu HJ, Strauss GM, Sugarbaker DJ. Kwiatkowski DJ, et al. Among authors: harpole dh jr. J Clin Oncol. 1998 Jul;16(7):2468-77. doi: 10.1200/JCO.1998.16.7.2468. J Clin Oncol. 1998. PMID: 9667266

9

Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients.

Harpole DH Jr, Marks JR, Richards WG, Herndon JE 2nd, Sugarbaker DJ. Harpole DH Jr, et al. Clin Cancer Res. 1995 Jun;1(6):659-64. Clin Cancer Res. 1995. PMID: 9816029

10

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers.

D'Amico TA, Massey M, Herndon JE 2nd, Moore MB, Harpole DH Jr. D'Amico TA, et al. Among authors: harpole dh jr. J Thorac Cardiovasc Surg. 1999 Apr;117(4):736-43. doi: 10.1016/s0022-5223(99)70294-1. J Thorac Cardiovasc Surg. 1999. PMID: 10096969 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters